Product Information
ARMODAFINIL 150 MG TABLET is a generic product labeled by Sandoz Inc., priced at $0.7876 per EA under NDC 00781803731. Its NADAC has been published 509 times since Jan 4, 2017.
FDA first approved this application on Jun 15, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Sandoz Inc.NDC
00781803731
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARMODAFINILApproval Type
Authorized Generic (NDA)
FDA Application
NDA021875FDA Approved
6/15/2007
TE Code
AB
On Market Since
12/1/2016
Price Statistics
The NADAC for ARMODAFINIL 150 MG TABLET has been published 509 times since Jan 4, 2017, and over the history we have for it it has declined 95.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7876 per EA |
|---|---|
| All-time high | $17.0365 (Jan 11, 2017) |
| All-time low | $0.5352 (Nov 20, 2024) |
| 52-week high | $0.8371 |
| 52-week low | $0.7698 |
| Median price | $0.8620 |
| Average price | $1.2005 |
| Largest weekly change | -87.3% (Feb 22, 2017) |
| Weeks tracked | 509 |
| Tracking since | Jan 4, 2017 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Armodafinil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARMODAFINIL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARMODAFINIL 150 MG TABLET, manufactured by Sandoz Inc., is $0.7876 per EA (NDC 00781803731), effective Sep 30, 2026.
How has the price of ARMODAFINIL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARMODAFINIL 150 MG TABLET has declined 95.4%. It has been tracked across 509 weekly CMS publications since Jan 4, 2017.
What are the highest and lowest recorded NADAC prices for ARMODAFINIL 150 MG TABLET?
Since Jan 4, 2017, the NADAC for ARMODAFINIL 150 MG TABLET has ranged from a low of $0.5352 (Nov 20, 2024) to a high of $17.0365 (Jan 11, 2017), with a median of $0.8620 per EA.
Are there cheaper alternatives to ARMODAFINIL 150 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARMODAFINIL 150 MG TABLET, is $0.7517 per EA — about 5% below ARMODAFINIL 150 MG TABLET.
Who manufactures ARMODAFINIL 150 MG TABLET?
ARMODAFINIL 150 MG TABLET (NDC 00781803731) is labeled by Sandoz Inc., and CMS classifies it as a generic product.